Vaxcell-Bio Therapeutics Market Cap

Vaxcell-Bio Therapeutics has a market cap or net worth of 185.59 billion as of March 20, 2026. Its market cap has decreased by -13.39% in one year.

Market Cap

185.59B

Enterprise Value

147.55B

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

7,980.00

Market Cap Chart

Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 185.59B, an increase of 15.82%. That is a compound annual growth rate of 2.71%.

Market Cap History

Date	Market Cap	% Change
Mar 20, 2026	185.59B	-20.12%
Dec 30, 2025	232.34B	-3.12%
Dec 30, 2024	239.82B	-53.54%
Dec 28, 2023	516.20B	-0.71%
Dec 29, 2022	519.87B	-21.31%
Dec 30, 2021	660.68B	-73.75%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Sep 22, 2020	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
JETEMA,	311.00B
Bioneer	305.08B
HLB Therapeutics	278.13B
Helixmith	257.40B
EASY BIO,Inc.	226.94B
Genexine	208.07B
MedPacto	181.66B
Macrogen	172.92B

Market Cap Rankings